Lev Verkh
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
- Biochemistry top 5%
- Blood transfusion and management
Papers in
- Co-authors
- Michael L. Levy (1 shared paper)Nabil Dib (1 shared paper)John Ross Crawford (1 shared paper)Steven C. Cramer (1 shared paper)Jihao Zhou (1 shared paper)John Smeraglia (1 shared paper)Laurie Jill Sherman (1 shared paper)Karen J. Klamerus (1 shared paper)
- Journals
- Biopolymers (2 papers)The Breast (2 papers)Blood (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Alzheimer s & Dementia (1 paper)
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
Lev Verkh
19 papers receiving 667 citations
Peers
Comparison fields: 5 of 67
- Genetics 117
- Biochemistry 74
- Developmental Neuroscience 20
- Pharmacology 60
- Hematology 60
Countries citing papers authored by Lev Verkh
This map shows the geographic impact of Lev Verkh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lev Verkh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lev Verkh more than expected).
Fields of papers citing papers by Lev Verkh
This network shows the impact of papers produced by Lev Verkh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lev Verkh. The network helps show where Lev Verkh may publish in the future.
Co-authors
The 25 scholars most cited alongside Lev Verkh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 155 | |
| 2 | 2006 | 120 | |
| 3 | 2002 | 116 | |
| 4 | 2000 | 77 | |
| 5 | 1989 | 45 | |
| 6 | 2009 | 45 | |
| 7 | 2009 | 35 | |
| 8 | 1982 | 22 | |
| 9 | 2012 | 21 | |
| 10 | 2012 | 19 | |
| 11 | 1997 | 18 | |
| 12 | 1980 | 13 | |
| 13 | 2015 | 9 | |
| 14 | Expression of nucleolar antigen p145 in bone marrow cells of patients with myeloid leukemias. | 1989 | 6 |
| 15 | 1986 | 4 | |
| 16 | 2016 | 2 | |
| 17 | 1982 | 1 | |
| 18 | Tolerability of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer : Abstract #4120 | 2009 | 1 |
| 19 | 2021 | 1 |
About Lev Verkh
Lev Verkh is a scholar working on Genetics, Oncology, Hematology, Cancer Research and Biochemistry, having authored 19 papers that have together received 710 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (4 papers), Cancer Treatment and Pharmacology (3 papers), Acute Myeloid Leukemia Research (2 papers), Fractal and DNA sequence analysis (2 papers), Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Lung Cancer Treatments and Mutations (1 paper) and Blood transfusion and management (1 paper). The work is most often cited by research in Genetics (117 citations), Biochemistry (74 citations), Developmental Neuroscience (20 citations), Pharmacology (60 citations) and Hematology (60 citations). Lev Verkh has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Michael L. Levy, Nabil Dib, John Ross Crawford, Steven C. Cramer, Jihao Zhou, John Smeraglia, Laurie Jill Sherman, Karen J. Klamerus, Carlo L. Bello and Leonard G. Gomella. Their work appears in journals such as Biopolymers, The Breast, Blood, Cancer Chemotherapy and Pharmacology and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.